Literature DB >> 17988303

Pancytopenia and secondary myelofibrosis could be induced by primary hyperparathyroidism.

D-J Lim1, E J Oh, C-W Park, H-S Kwon, E-J Hong, K-H Yoon, M-I Kang, B-Y Cha, K-W Lee, H-Y Son, S-K Kang.   

Abstract

Hyperparathyroidism may be a precipitating factor important to the development of myelofibrosis: however, there has been only a few reports regarding myelofibrosis secondary to primary hyperparathyroidism. Recently, a rare case of pancytopenia caused by myelofibrosis in a 41-year-old woman who complained of general weakness and arthralgia presented to our clinical service. The patient was diagnosed with primary hyperparathyroidism with pancytopenia. Bone marrow biopsy revealed myelofibrosis. Right parathyroidectomy was performed and a parathyroid adenoma was totally excised. After surgery, the CBC counts and other clinical abnormalities gradually improved without further intervention. We concluded that the pancytopenia was because of bone marrow fibrosis resulting from primary hyperparathyroidism. Therefore, physicians should consider myelofibrosis secondary to primary hyperparathyroidism as a cause of pancytopenia in hypercalcemic patients, even though it is rare.

Entities:  

Mesh:

Year:  2007        PMID: 17988303     DOI: 10.1111/j.1365-2257.2006.00877.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  5 in total

Review 1.  PTH and stem cells.

Authors:  M Ohishi; E Schipani
Journal:  J Endocrinol Invest       Date:  2011-03-22       Impact factor: 4.256

2.  A novel population of cells expressing both hematopoietic and mesenchymal markers is present in the normal adult bone marrow and is augmented in a murine model of marrow fibrosis.

Authors:  Masanobu Ohishi; Wanida Ono; Noriaki Ono; Richa Khatri; Marilena Marzia; Emma K Baker; Sierra H Root; Tremika Le-Shan Wilson; Yukihide Iwamoto; Henry M Kronenberg; Hector L Aguila; Louise E Purton; Ernestina Schipani
Journal:  Am J Pathol       Date:  2011-12-05       Impact factor: 4.307

Review 3.  Calcium regulation of stem cells.

Authors:  Hans-Willem Snoeck
Journal:  EMBO Rep       Date:  2020-05-17       Impact factor: 8.807

4.  Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.

Authors:  Nidhi Mehra; Armon Varmeziar; Xinyu Chen; Olivia Kronick; Rachel Fisher; Vamsi Kota; Cassie S Mitchell
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

5.  Older Age and High Serum Ferritin Levels Associated With the Risk of Chronic Cytopenia in Hemodialysis Patients.

Authors:  Yu-Ting Lee; Wei-Yu Wang; Chin-Ho Kuo; Ming-Yang Lee; Yin-Che Lu; Chih-Yen Hsiao; Yueh-Han Hsu; Peir-Haur Hung
Journal:  Front Med (Lausanne)       Date:  2020-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.